Earnings calls

Pfizer concall ledger

Every earnings call for PFIZER — management tone, guidance, KPIs and promise tracking, quarter by quarter.

PFIZER · 5 transcripts · Healthcare · latest Q1 FY21

Q1 FY21Published 05 Aug 2020Call held 05 Aug 2020

PFIZER Q1 FY21 Earnings Call Transcript & Analysis

Revenue from Operations₹515 cr−5% YoYEBITDA Margin37%PAT₹124 cr+10% YoY

Revenue from Operations ₹515 cr (−5% YoY); EBITDA Margin 37%; PAT ₹124 cr (+10% YoY). Revenue from operations stood at ₹515 crores, a decline of 5.3% YoY due to COVID-19 impact on hospital and vaccine segments.

Read full transcript & analysis

Q4 FY17Published 18 May 2017Call held 18 May 2017

PFIZER Q4 FY17 Earnings Call Transcript & Analysis

Revenue₹453 cr−15% YoYNet Profit₹65 cr−26% YoY

Revenue ₹453 cr (−15% YoY); Net Profit ₹65 cr (−26% YoY). Revenue from operations for Q4 stood at ₹453 crores, a decline of 15.3% YoY due to regulatory and pricing impacts.

Read full transcript & analysis

Q3 FY17Published 01 Feb 2017Call held 01 Feb 2017

PFIZER Q3 FY17 Earnings Call Transcript & Analysis

Revenue₹503 cr−3% YoYPAT—+4% YoYGross Margin60%

Revenue ₹503 cr (−3% YoY); Gross Margin 60%. Reported Revenue of ₹503 crores, a decline of 3% YoY due to structural changes and demonetization.

Read full transcript & analysis

Q2 FY17Published 07 Nov 2016Call held 07 Nov 2016

PFIZER Q2 FY17 Earnings Call Transcript & Analysis

Revenue₹552 cr+5% YoY

Revenue ₹552 cr (+5% YoY). Revenue of ₹552 crores, representing a 5% YoY growth.

Read full transcript & analysis

Q1 FY17Published 08 Aug 2016Call held 08 Aug 2016

PFIZER Q1 FY17 Earnings Call Transcript & Analysis

Revenue Growth3%+3% YoYPBT (before exceptional items) Growth-7%−7% YoYEffective Tax Rate35%Amortization Benefit₹16.4 crExceptional Income₹7.93 cr

Revenue Growth 3% (+3% YoY); PBT (before exceptional items) Growth -7% (−7% YoY); Effective Tax Rate 35%. Revenue growth was soft at 3% YoY, significantly impacted by regulatory challenges and pricing policies.

Read full transcript & analysis